Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease
Public ClinicalTrials.gov record NCT00295165. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-Blind, Placebo-Controlled, Phase 3 Induction Study to Assess the Efficacy and Safety of 6µg Sargramostim (Leukine) Administered Subcutaneously Once Daily for 8 Weeks in Patients With Active Crohn's Disease
Study identification
- NCT ID
- NCT00295165
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Genzyme, a Sanofi Company
- Industry
- Enrollment
- 33 participants
Conditions and interventions
Conditions
Interventions
- Sargramostim (Leukine) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2005
- Primary completion
- Sep 30, 2006
- Completion
- Sep 30, 2006
- Last update posted
- Dec 3, 2013
2006
United States locations
- U.S. sites
- 47
- U.S. states
- 23
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | 35801 | — |
| Not listed | Orange | California | 92868 | — |
| Not listed | San Francisco | California | 94117 | — |
| Not listed | Lakewood | Colorado | 80215 | — |
| Not listed | Littleton | Colorado | 80120 | — |
| Not listed | Washington D.C. | District of Columbia | 20007-2197 | — |
| Not listed | Boca Raton | Florida | 33486 | — |
| Not listed | Gainesville | Florida | 32610-0254 | — |
| Not listed | Atlanta | Georgia | 30342 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | Lexington | Kentucky | 40536 | — |
| Not listed | Louisville | Kentucky | 40202 | — |
| Not listed | Hagerstown | Maryland | 21740 | — |
| Not listed | Lutherville | Maryland | 21093 | — |
| Not listed | Towson | Maryland | 21204 | — |
| Not listed | Ann Arbor | Michigan | 48109-0330 | — |
| Not listed | Chesterfield | Michigan | 48047 | — |
| Not listed | Troy | Michigan | 48098 | — |
| Not listed | Plymouth | Minnesota | 55446 | — |
| Not listed | Mexico | Missouri | 65265 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Lincoln | Nebraska | 68503 | — |
| Not listed | Florham Park | New Jersey | 07932 | — |
| Not listed | New Brunswick | New Jersey | 08901 | — |
| Not listed | Great Neck | New York | 11021 | — |
| Not listed | Mineola | New York | 11501-3987 | — |
| Not listed | New York | New York | 10028 | — |
| Not listed | Syracuse | New York | 13210 | — |
| Not listed | Charlotte | North Carolina | 28207 | — |
| Not listed | Raleigh | North Carolina | 27612 | — |
| Not listed | Winston-Salem | North Carolina | 27157 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Cincinnati | Ohio | 45242 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Dayton | Ohio | 45440 | — |
| Not listed | Oklahoma City | Oklahoma | 73104 | — |
| Not listed | Tulsa | Oklahoma | 74104 | — |
| Not listed | Sayre | Pennsylvania | 18840 | — |
| Not listed | Columbia | South Carolina | 29203 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Charlottesville | Virginia | 22908 | — |
| Not listed | Chesapeake | Virginia | 23320 | — |
| Not listed | Christiansburg | Virginia | 24073 | — |
| Not listed | Norfolk | Virginia | 23502 | — |
| Not listed | Richmond | Virginia | 23249-0002 | — |
| Not listed | Seattle | Washington | 98195 | — |
| Not listed | Wenatchee | Washington | 98801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00295165, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 3, 2013 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00295165 live on ClinicalTrials.gov.